Clinical trial
An Open Label Phase I/II Study of the Safety and Dopamine Transporter Binding…
NCT00302380 · Massachusetts General Hospital, Other · Completed
Key facts
| NCT number | NCT00302380 |
|---|---|
| Title | An Open Label Phase I/II Study of the Safety and Dopamine Transporter Binding Properties of C-11 Altropane in Normal Human Subjects and in Subjects With ADHD |
| Official title | An Open Label Phase I/II Study of the Safety and Dopamine Transporter Binding Properties of C-11 Altropane in Normal Human Subjects and in Subjects With ADHD |
| Lead sponsor | Massachusetts General Hospital, Other |
| Collaborators | National Institute of Mental Health (NIMH) NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Attention Deficit Hyperactivity Disorder |
| Intervention type | Radiation |
| Interventions | PET imaging using C-11 altropane as the ligand. |
| Enrollment | 300 |
| Start date | Oct 1, 2000 |
| Primary completion | Mar 1, 2006 |
| Completion | Mar 1, 2006 |
| First posted | Mar 14, 2006 |
| Last update posted | Jun 28, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: